| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1721d75f5bf603447ec5a26b5c1c0be0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3619ddae54c8e781d217253ad49003b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dd33980532456d9e27901126ea642f28 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate |
2010-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_833d1ae7387fb95accc1df5a77118a36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1279b6af658d7446377a4a57d550e74c |
| publicationDate |
2011-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011017106-A9 |
| titleOfInvention |
Skp2 as a biomarker for rapamycin resistance |
| abstract |
The present invention provides a method for identifying tumors that are resistant to rapamycin therapy, such that a more efficacious treatment plan can be designed and administered. In particular, the present invention provides methods for identifying a rapamycin resistant tumors based on the expression levels of Skp2. |
| priorityDate |
2009-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |